XCath Raises $30M Series C to Advance Neurovascular Surgical Robotics

Team S · 2026-03-16T13:56:01.000Z

XCath has raised $30 million in a Series C funding round co-led by Crescent Enterprises and surgical robotics pioneer Fred Moll. The new capital will support the continued development and commercialization of the company’s endovascular surgical robotics platform, designed to improve treatment for stroke and other neurovascular diseases. With this latest round, the total funding raised by XCath has reached $92 million since its founding in 2017. The company is developing advanced robotic technologies aimed at improving outcomes in minimally invasive neurovascular procedures. The funding will accelerate development of XCath’s Iris robotic system, which is being designed as the world’s first commercially practical endovascular robotic platform capable of performing complex procedures such as telerobotic mechanical thrombectomy. The technology aims to allow physicians to perform delicate neurovascular interventions with greater precision and potentially expand access to life-saving care in regions with limited specialists. In November 2025, the Iris system was used in first-in-human procedures to treat patients with complex brain aneurysms at The Panama Clinic in Panama City. The milestone marked only the second time a surgical robot has been used in an intracranial neurovascular intervention, highlighting the potential of robotic technology in advanced neurosurgical procedures. According to Eduardo Fonseca, the investment will help accelerate the company’s mission to expand access to advanced stroke treatment and other neurovascular interventions worldwide. XCath operates from Houston, Texas, and Pangyo, South Korea, and is focused on developing next-generation robotic solutions for minimally invasive vascular surgery. The Iris system is currently under development and has not yet been cleared for commercial distribution.

Member Login Get Access

XCath Raises $30M Series C to Advance Neurovascular Surgical Robotics | Newnex